MedPath

山东先声生物制药有限公司

Ownership
-
Established
1999-06-30
Employees
-
Market Cap
-
Website
https://www.simcere.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Recombinant Human Endostatin Injection

Product Name
恩度
Approval Number
国药准字S20050088
Approval Date
Nov 13, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.